Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Liposarcoma × Blood Specimen Collection × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 15 Neoplasms 6 Gastrointestinal Stromal Tumors 4 Osteosarcoma 3 Melanoma 3 Uterine Cervical Neoplasms 2 Testicular Neoplasms 2 Prostatic Neoplasms 2 Neuroblastoma 2 Neoplasm Metastasis 2 Lymphoma 2 Glioma 2 Esophageal Neoplasms 2 Desmoid Tumors 2 Breast Neoplasms 2 Wilms Tumor 1 Uveal Melanoma 1 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Somatostatinoma 1 Skin Neoplasms 1 Sarcoma, Myeloid 1 Sarcoma, Ewing 1 Oligodendroglioma 1 Neoplastic Cells, Circulating 1 Neoplasms, Plasma Cell 1 Lung Neoplasms 1 Liposarcoma 1 Leukemia, Myeloid, Acute 1 Leukemia 1

Interventions

Doxorubicin 20 Trabectedin 10 Radiotherapy 10 Ifosfamide 10 pazopanib 5 Gemcitabine 5 ribociclib 4 Specimen Handling 4 Docetaxel 4 Biopsy 4 selinexor 3 pembrolizumab 3 palbociclib 3 eribulin 3 X-Rays 3 Filgrastim 3 Cyclophosphamide 3 temsirolimus 2 pegfilgrastim 2 liposomal doxorubicin 2 cixutumumab 2 brostallicin 2 brigimadlin 2 belinostat 2 avelumab 2 abemaciclib 2 Vincristine 2 Temozolomide 2 Surgical Procedures, Operative 2 Sunitinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04224064 2025-02-12

ESPACE

Institut du Cancer de Montpellier - Val d'Aurelle

Phase NA Recruiting

Liposarcoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡